Table 2.

Summary of results of clinical trials of decitabine in MDS

Summary of results of clinical trials of decitabine in MDS
Summary of results of clinical trials of decitabine in MDS

CMML indicates chronic myelomonocytic leukemia; ND, not described; PR, partial remission; HI, hematologic improvement; ORR, overall response rate (CR + PR + HI); and Cyto, cytogenetic response.

*Dysplasia possible.

†IWG 2000 criteria.

or Create an Account

Close Modal
Close Modal